Article
Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.
Molecular oncology - 1 Oct 2014
Li Changyou, Egloff Ann Marie, Sen Malabika, Grandis Jennifer R, Johnson Daniel E
Abstract excerpt
Little is known regarding molecular markers in head and neck squamous cell carcinoma (HNSCC) that predict responsiveness to different therapeutic regimens or predict HNSCC progression. Mutations in procaspase-8 occur in 9% of HNSCC primary tumors, but the functional consequences of these mutations are poorly understood. In this study, we examined the impact of four, representative, HNSCC-associated procaspase-8...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
